Tomomi Kurashige, Mika Shimamura, Koichiro Hamada, Michiko Matsuse, Norisato Mitsutake, Yuji Nagayama. Characterization of metabolic reprogramming by metabolomics in the oncocytic thyroid cancer cell line XTC.UC1. Scientific Reports. 2023. 13. 1
Toyoyoshi Uchida, Mika Shimamura, Hikari Taka, Naoko Kaga, Yoshiki Miura, Yuya Nishida, Yuji Nagayama, Hirotaka Watada. The effect of long-term inorganic iodine on intrathyroidal iodothyronine content and gene expression in mice with Graves' hyperthyroidism. Thyroid : official journal of the American Thyroid Association. 2022
Koichiro Hamada, Tomomi Kurashige, Mika Shimamura, Hirofumi Arakawa, Yasuyuki Nakamura, Yuji Nagayama. MIEAP and ATG5 are tumor suppressors in a mouse model of BRAFV600E-positive thyroid cancer. Frontiers in Endocrinology. 2022. 13
Darya Kazakova, Mika Shimamura, Tomomi Kurashige, Koichiro Hamada, Yuji Nagayama. Re-evaluation of the role of autophagy in thyroid cancer treatment. Endocrine journal. 2022. 69. 7. 847-862
Acceleration of BRAF <SUP>V600E</SUP> induced thyroid carcinogenesis by TGFβ signal deficiency in mice
(The 80th Annual Meeting of the Japanese Cancer Association 2021)
Intracellular redox status controls spherogenicity in thyroid cancer cells
(2018)
甲状腺癌幹細胞の特性の検討(ROSを指標にして)
(2017)
Mouse Models of Thyroid Cancer with BRAFV600E Mutation
(2017)